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ABSTRACT
Background and aim: How patients use their
nebulisers at home is vital to ensure effective treatment
and optimal health outcomes for patients with chronic
obstructive pulmonary disease (COPD). The aim of the
study was to identify the practicalities and problems
associated with nebuliser use by patients with COPD at
home, which may impact on the safety and
effectiveness of therapy.
Design and setting: A cross-sectional descriptive
study in which participants were recruited from two
levels of care: primary care, involving 38 GP practices
in North West London, and intermediate care with a
major acute hospital.
Method: In-depth interviews were conducted with a
representative sample of 50 patients with COPD using
nebulisers in their home, recruited from general
practice populations and at hospital discharge. A
checklist was used to record activities and patients
demonstrated use of their nebuliser. Qualitative
procedures were employed to identify the range of
problems experienced with nebuliser use.
Results: A wide range of practical issues was
identified at all stages: problems prior to nebulisation:
setting up equipment, lack of instructions, manual
dexterity and time required. Problems during
medication administration: inhalation technique,
duration of nebulisation and understanding how to
achieve optimal efficacy. Problems post-administration:
inadequate cleaning of nebuliser components, access
to accessories and use of damaged parts or
self-repairs. Other problems included noise, weight and
non-portability of equipment.
Conclusions: Patients with COPD using nebulisers at
home experienced problems with all aspects, many of
which may be anticipated to compromise clinical
outcomes. Healthcare providers should be aware of
these problems to effectively support patients with
COPD with the use of their nebulisers at home.
INTRODUCTION
Nebuliser therapy is frequently prescribed
for management of chronic obstructive pul-
monary disease (COPD) in the home, and
may be valuable for patients who are elderly,
have difﬁculties with hand-held inhalers,
require high treatment doses or have
comorbidities.
12About half of the patients
who remain breathless despite high-dose
bronchodilators delivered by pressurised
metered dose inhalers (pMDIs) or dry
powder inhalers (DPIs), derive beneﬁts from
domiciliary nebuliser therapy.
3 Studies have
shown that nebuliser therapy has a role in
the management of severe COPD in the
community,
4–6 with a positive impact on
quality of life.
The correct use of inhaler devices is
crucial in achieving successful therapy.
7 The
use of inhaler devices poses challenges for
older patients,
28and has been linked to sub-
optimal health outcomes. While pMDI and
DPI use has been extensively studied,
29 –12
nebuliser use has attracted less attention. In
the few studies investigating nebuliser use by
patients with COPD in the home, problems
have been reported with assembling nebu-
liser equipment
13 and gauging how long to
nebulise ﬂuids.
14 Inadequate cleaning of
equipment after use has been highlighted in
several studies.
13–18 While a number of pro-
blems have been identiﬁed, a comprehensive
study of home nebuliser use, from the per-
spectives of patients with COPD, to identify
KEY MESSAGES
Patients with chronic obstructive pulmonary disease
(COPD) using nebulisers at home experienced pro-
blems at all stages, including problems prior to
nebulisation: setting up equipment, lack of instruc-
tions, manual dexterity and time required. Problems
during medication administration: inhalation tech-
nique, duration of nebulisation and understanding
how to achieve optimal efficacy. Problems post-
administration: inadequate cleaning of nebuliser
components, access to accessories and use of
damaged parts or self-repairs. Other problems
included noise, weight and non-portability of equip-
ment. Healthcare providers should be aware of
these problems to effectively support patients with
COPD with the use of their nebulisers at home.
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failure, has not been undertaken.
The aim of this study was to examine nebuliser use
for the daily management of COPD from the perspec-
tives of patients. Mixed methods were employed, with
collection of data in patients’ own homes to reﬂect
their natural settings, and provide an understanding of
difﬁculties and problems they experience. This study
was designed to highlight problems and practices that
may result in suboptimal clinical outcomes across all
stages of nebuliser use. The study will inform the devel-
opment of services to support this patient group in
achieving more effective management of their
condition.
METHODS
Data were collected in semistructured interviews in
patients’ homes. Participants were recruited from two
settings: a primary care setting comprising 38 GP surger-
ies, and an intermediate care setting (healthcare and
rehabilitation team located at a major acute hospital).
This enabled inclusion of patients whose disease was
being adequately managed in the community, and those
recently admitted to hospital for an exacerbation, sug-
gestive of treatment failure. Eligible patients had a con-
ﬁrmed diagnosis of COPD and were prescribed
nebules/Respules and/or Combivent (ipratropium and
salbutamol) for use with a nebuliser at home. All
patients eligible to participate were identiﬁed through
the collaborators at the study sites. All potential partici-
pants were then reviewed by their treating doctors, who
identiﬁed those they believed should be excluded
because of mental health problems or severe cognitive
impairment, or because they were unwell or had other
serious illness. An invitation pack was sent to all eligible
patients. Home interviews were arranged with those
patients who returned a reply slip indicating willingness
to participate. Informed consent was obtained prior to
data collection.
The interview schedule comprised structured and
open questions to identify and explore the range of
experiences associated with nebuliser use in the home.
All participants were asked to describe and demonstrate
how they set up and operated their nebuliser system,
while the researcher observed and recorded their tech-
nique using a checklist developed for this study. They
were asked how they assembled the different compo-
nents of the nebuliser, diluted drug ﬂuid (if required),
mixed drug formulations (if two formulations were
used), ﬁlled ﬂuid into the nebuliser reservoir and how
they operated the compressor. The patients were also
asked to demonstrate how they ﬁtted the facemask on
their face or used the mouthpiece and inhaled their
nebulised dose. They were asked to demonstrate and
describe how they dismantled, cleaned and dried nebu-
liser parts after nebulisation, and to indicate the fre-
quency with which they replaced nebuliser parts and
serviced the compressor. Patients were observed by the
researcher while they demonstrated their cleaning and
drying techniques. In addition to structured question
and check lists, open questions relating to all aspects of
nebuliser use enabled detailed discussion of patients’
experiences and difﬁculties. The checklist and all instru-
ments were piloted and revised in collaboration with the
study team prior to the collection of data. Interviews
were audio recorded and transcribed verbatim.
Structured data were entered into SPSS for descriptive
analyses. For data gathered in response to open ques-
tions, analysis was facilitated by using the FRAMEWORK
software (NatCen). This enabled systematic application
of qualitative procedures (especially a themed approach
employing constant comparison), such that concepts
remain grounded in the data.
RESULTS
Characteristics of participants
Of 180 patients who were sent invitation packs, 83
returned the reply slip, of whom 60 agreed to take part.
The collection of data continued until the target
number of 50 patients was achieved. The participants
comprised 21 male and 29 female patients with a mean
age of 71 years. Thirty-two lived alone and 15 were
assisted by a family carer. Forced expiratory volume in
1 s (FEV1, % predicted) from patients’ medical records
was used to indicate severity of disease. For 24 patients,
disease was severe (30–49%), for 16, moderate (50–
79%) and for 10 patients, mild (≥80%). The mean dur-
ation of nebuliser use was 9 years (range 6 months to
30 years). Patients were using 12 different models/
makes of jet nebuliser in combination with 1 of 12
makes/models of compressor, or 1 of 5 ultrasonic or
mesh nebulisers.
The use of nebuliser therapy in the home
Table 1 shows the deviations from correct nebuliser use as
observed by the researcher. Those deviations that may
compromise drug delivery are highlighted. The data from
the observations are considered, combined with the pro-
blems and difﬁculties reported by patients in the inter-
views, with themes identiﬁed from the patients’ accounts
described in relation to speciﬁc activities. Findings are pre-
sented in relation to three stages: prior to inhaling the
dose, inhaling the drug via the nebuliser, and dismantling
and cleaning equipment following dosing.
Problems in setting up the nebuliser
Assembling components of the nebuliser system
Patients are required to set up their nebuliser system,
comprising: a nebuliser chamber, medication, accessor-
ies (facemask or mouthpiece), tubing and a compres-
sor. Eleven patients revealed that their nebuliser system
was assembled at all times (even when not in use), so
that they were not required to assemble parts for each
use. The most common reasons for this were limited
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disease ﬂare ups. These patients regarded themselves as
having control over their condition: having the
nebuliser set up eliminated panicking during the onset
of attacks by ensuring medication could be adminis-
tered quickly.
Table 1 Problems encountered by patients using nebuliser therapy in the management of chronic obstructive pulmonary
disease
Theme Description of step performed incorrectly
N
(50)
Assembling and
operating
Failure to remove the nebuliser cap from the medication tank* 11
Failure to ensure the vaporiser head is freely moving prior to filling the drug fluid* 22
Failure to reinsert the vaporiser head in the medication tank** 3
Failure to reconnect the nebuliser cap to the medication tank* 1
Failure to fit the facemask/mouthpiece on the nebuliser cap* 4
Failure to connect the tubing to the medication tank from one end and to the
compressor from the other*
6
Failure to switch on the compressor** 0
Filling drug fluid Failure to store the nebuliser fluid correctly 0
Failure to use the nebuliser fluid at room temperature 0
Failure to prepare the nebuliser fluid immediately prior to use 3
Failure to dilute the nebuliser fluid* 0
Failure to mix the drug formulations 0
Failure to fill the medication tank with the drug fluid* 6
Compatibility Failure to use the correct nebuliser for the drug* 0
Failure to use the correct nebuliser for the compressor? 25
Failure to use compatible drug formulations*
Patient/device
interface
Failure to fit the facemask/holds the mouthpiece* 6
Inhalation technique Failure to sit in an upright position* 2
Failure to inhale from the mouth* 17
Breathing pattern Failure to inhale slowly* 23
Failure to inhale as deeply as possible* 28
Failure to hold breath for few seconds before exhaling* 39
End point Failure to define an end point to stop nebulisation 5
Dismantling Failure to switch off the compressor 0
Failure to detach the nebuliser from the tubing 9
Failure to dismantle the nebuliser (cap/medication tank/vaporiser head) 14
Cleaning Failure to wash hands before handling the drug 45
Failure to run the machine for some time with saline/empty* 44
Failure to rinse the parts (except the tubing) under hot water after use* 31
Failure to disinfect the parts (except the tubing) with a suitable disinfectant once a
day*
46
Failure to wipe the compressor and tubing at least once a day with a damp cloth 34
Failure to discard the remaining drug fluid* 16
Failure to reassemble and place the nebuliser in a clean bag/tubing placed inside
compartment
28
Failure to close the lid when not in use 15
Drying Failure to leave the parts to dry on a clean tissue 20
Failure to run the machine until no moisture remains in the tubing 42
Failure to hang the tubing to dry 32
Equipment misuse Failure to place the equipment on a flat surface 16
Failure to place the equipment at least 4 inches away from any other equipment 27
Maintenance Failure to replace the tubing according to manufacturer’s recommendations* 36
Failure to replace the nebuliser according to manufacturer’s recommendations* 37
Failure to replace the facemask/mouthpiece according to manufacturer’s
recommendations*
36
Failure to check the filter monthly and to replace it according to manufacturer’s
recommendations*
37
Failure to service the equipment annually and to check it for any electrical fault* 39
Steps highlighted in bold are likely to result in either a reduced drug output (*), no drug output (**) or an unknown drug output (?), if
performed incorrectly by the patient.
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need it, you probably, to help not panic the best thing is
to get it going as soon as possible. So next to that chair,
I’ve actually got the nebules, and that’s already set up,
and is there, and with very little movement I can get it. I
sit in the chair, pull the top off, and squirt the thing
[nebule] in… (Participant 37, nebuliser user for
10 years)
When nebulisation was required, these patients ﬁlled
the medication tank either by removing the nebuliser
cap (n=6), or through the opening in the facemask
(n=5). The latter, regarded by some patients as more
convenient than unscrewing the cap, was justiﬁed by
explaining that the medication ends up in the reservoir.
All but three patients failed to ensure that the vapor-
iser head/bafﬂes was freely moving prior to ﬁlling the
drug ﬂuid (n=47). This may mean the part not rotating
freely, potentially affecting vapour output and properties
of the emitted aerosol. Those who had their nebuliser
set up at all times adopted inadequate cleaning proce-
dures, and the vaporiser head was frequently found to
be stuck and/or not rotating when the compressor was
started. Even when the patients assembled the nebuliser
prior to each use (n=39), all but three failed to ensure
that the vaporiser head moved freely, either not under-
standing this part’s function, or not knowing it was
detachable. In one case, the patient thought it should
be tight ﬁtting.
I use one ampoule and then I put it in there tighten that
(the vaporiser head), it has to be secure, then put that
back on (the nebuliser cap) and then I use the mask…
(Participant 44, nebuliser user for 3 years)
Three patients described instances where they forgot
to replace the vaporiser head in the chamber, while only
three clearly understood the importance of this part
being freely moving:
If anything goes wrong, I would think the piece to go
wrong would be here [vaporiser head], although it would
fail to vaporise and you wouldn’t get anything out of
here. Well you would, but it wouldn’t be any good…
(Participant 7, nebuliser user for 6 months)
With regard to connecting the tubing to the compres-
sor or nebuliser, difﬁculties arose due to poor manual
dexterity and poor grip (n=6). As a result, some patients
had to rely on help from a carer.
No patients experienced problems with operating the
compressor (plugging it into the mains and/or pressing
the power button).
Filling nebuliser fluid
All but three patients prepared drug ﬂuid immediately
prior to use. Six patients reported experiencing pro-
blems with this step. Two reasons were identiﬁed: confu-
sion about which product/formulation to use, and the
physical and functional limitations of the patient (poor
grip and eyesight). In these cases, patients relied on
carers for assistance. Difﬁculties were described in
opening medication vials (nebules): one patient com-
mented on the difﬁculty of opening some vials, but not
others.
Some of them I ﬁnd quite difﬁcult to twist to separate…
I’ve had ones that are quite difﬁcult, that I have to go off
and get help; these are easy… (Participant 13, nebuliser
user for 10 years)
Diluting the nebuliser fluid
Diluting drug ﬂuid increases the volume nebulised,
increasing drug output for a ﬁxed residual volume and
increasing duration of nebulisation.
One patient reported only sometimes diluting the
drug formulation, and did not know why dilution was
required. He described being confused that dilution was
not carried out in hospital and was uncertain about the
amount of saline to be used for dilution.
They’re a big tube (saline) and you take it by injection
2 ml or 2.5 ml and put it in there (the chamber) and use
it. But I have no idea why it is this amount, no idea, even
the doctor never told me. (Participant 24, nebuliser user
for 6 months)
One patient thought the dilution was to mask the taste
of her medication, while another was substituting saline
with distilled or boiled water. A further patient was using
expired saline vials. This patient did not feel this was
problematic as they were sealed, and she was considering
using an irrigation solution (prescribed for her leg
wound) in her nebuliser.
Problems occurring during inhalation of the nebulised
dose
The patient/device interface
Forty patients were using facemasks; 10 used mouth-
pieces. Six patients experienced problems ﬁtting their
facemask: two attached the mask to the nebuliser
inverted, and consequently could not ﬁt it properly on
their face. Three patients held the facemask with their
hand instead of fastening it securely to the face. Holding
was considered easier in one case, while two patients
were using facemasks missing an elasticated band, which
secures the mask to the head. This band was over-
stretched in another case, and one patient was using
safety pins to repair an overstretched band and secure
the mask to his face.
In terms of patient preference, ﬁve patients preferred
a mouthpiece due to its relative ease of use and the
ability to synchronise their breathing with aerosol output
compared with the facemask.
I ﬁnd even the oxygen’s a menace, because you can’t
control it. What happens is it’s pumping into your mouth
all the time, whereby with this you are breathing it in and
out. This one [mouthpiece] you can control; the
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You can’t control the oxygen. (Participant 8, nebuliser
user for 15 years)
Six patients preferred a facemask, giving similar
reasons, including that they felt more secure with the
mask on and that it allowed for a more natural breathing
pattern.
I just feel more secure with it over [the face]. I just didn’t
feel as though it [mouthpiece] was doing me any good
at all, just in the mouth. (Participant 2, nebuliser user for
1 year)
Leakage of drug fluid
Some patients described ﬂuid leakage during nebulisa-
tion, reducing the amount available for inhalation.
Leakage occurred at the medication chamber/tubing
junction (n=3) due to overstretched tubing, or at the
medication chamber/cap joint (n=3) due to a cracked
nebuliser cap or incorrect assembling of the parts.
Well, it tends to stretch at the end [tubing] and it goes
too far, do you know what I mean, onto the chamber so
you get a leakage. (Participant 49, nebuliser user for
3 years)
If you overtighten it [nebuliser cap], or once it’s split,
then while you’re using it, it [ﬂuid] tends to go over the
top and run down and you end up with a pool on the
ﬂoor and it’s less efﬁcient that way. (Participant 32, nebu-
liser user for 18 months)
Additionally, two patients described incidents of
tubing ‘popping off’ the device during nebulisation,
explainable in both cases by the use of overstretched
tubing.
Concerns about aerosol cloud safety and feeling
claustrophobic
Ill-ﬁtting facemasks can result in drug deposition on the
face and in the eyes causing adverse effects, which is a
particular concern with inhaled steroids or for anti-
cholinergic drugs prescribed for patients with glaucoma.
Three participants expressed concerns about the safety
of the aerosol depositing on the face and getting into
the eyes.
I can’t use a facemask…I use a mouthpiece…I was aller-
gic and my eyes come up and my face comes up, so I use
the mouthpiece. (Participant 43, nebuliser user for
10 years)
Another problem reported was feeling ‘closed in’ and
claustrophobic with a facemask covering the entire face
(n=3).
I didn’t like using it [facemask] very much…I found it a
bit claustrophobic on your face. (Participant 38, nebu-
liser user for 1 year)
Inhalation technique and breathing pattern
All but two patients reported sitting in an upright pos-
ition during nebuliser use. Despite doing so, these
patients did not have a clear understanding as to why
this was important, other than it being more comfort-
able in this position. One patient described trying differ-
ent manoeuvres to enhance inhaling the medication.
I tend to sit in an easy chair…because I am more
relaxed, but as it comes towards the end there’s more,
you can get more by either sitting up, or even moving
forward a bit. So initially I am very pleased to sit back
and relax, and then move forward, because then it seems
to be more effective to get it out. (Participant 37, nebu-
liser user for 10 years)
Only six patients who were using facemasks were
breathing through their mouth, while the majority were
either breathing through their nose (n=17) or breathing
through mouth and nose (n=18). Clearly, patients who
were using a mouthpiece should be breathing through
their mouth. However, in one case, the patient was
breathing nasally despite using a mouthpiece.
Only 12 participants reported breathing slowly. The
patients explained that breathing at a slower rate is not
always possible, especially when their chest is ‘tight’.
The ﬁrst couple of minutes you are gasping, so you are
breathing fast, and then you’ve got to learn to regulate
your breathing. That’s what I’ve been trained to do by
the physiotherapist, and the doctors. (Participant 23,
nebuliser user for 4 years)
Several patients reported breathing deeply (n=20).
Although in most cases patients had not been instructed
on breathing technique, they recognised the importance
of deep breathing.
The other thing I try to do, normally, although I breathe
normally, I do at the beginning try to breathe well out
and take a very deep breath and hold on to it… Nobody
ever said do so, it just seems to me that if you breathe
very shallowly there’s some part of the lung that isn’t
getting the medication, and it probably ought to.
(Participant 37, nebuliser user for 10 years)
Holding the breath prior to exhalation was only per-
formed by a few patients (n=6). The majority reported
experiencing difﬁculties with holding their breath, espe-
cially during severe attacks.
It depends if my chest is tight. If my chest is tight then I
do [hold breath] momentarily, but I can’t always hold it
very long you know, so yes sometimes but not always.
(Participant 28, nebuliser user for 10 years)
Duration of nebulisation
The duration of nebulisation ranged from 2 to 40 min.
Most commonly, participants reported a time between
10 and 15 min (n=21), with four reporting greater than
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resumed from 2 h to 24 h later. Interruption was mainly
due to the inconvenience of long nebulisation sessions
(n=3).
Other reasons for interruption were: coughing (n=1),
blocked nose (n=1) and forgetting to return to the
nebuliser after a temporary stop (n=1).
Well, I tend to use it on and off rather than in one
straight go because I ﬁnd that after maybe a minute or
half a minute using it, then I have to clear my throat and
my nose because at the same time as the emphysema I
suffer, my nose blocks up very quick which makes it difﬁ-
cult for breathing so until I clear my nose I can’t clear
my chest. So I have to use it in small doses probably over
a 20 minute period. (Participant 32, nebuliser user for
18 months)
Defining an end point of nebulisation
The patients were asked to deﬁne the point at which
they should end nebulisation. All but ﬁve patients
deﬁned an appropriate end point.
Because the ﬂuid inside, it goes in here, because it
throws it up all over the place, so if you knock it you’ll
get all the ﬂuid down. So I knock it and knock it and
knock it, hold it on one side, and if there’sn oﬂuid in
the bottom I’m ﬁnished. If there’s any ﬂuid in the
bottom I just keep doing it until it’s all gone. (Participant
12, nebuliser user for 20 years)
Problems occurring after inhaling the nebulised dose
The problems encountered by patients after inhalation
related to dismantling, cleaning and maintenance.
Dismantling the nebuliser
After completing nebulisation, patients should switch off
the compressor, then dismantle and clean the compo-
nents of the nebuliser system. Fourteen patients did not
dismantle their nebuliser after use. Most of them
cleaned the nebuliser as a unit by running water
through the opening of the mask or the nebuliser cap,
shaking, and emptying out the water (n=11). Manual
dexterity was the commonest reason given by the
patients for failing to dismantle the equipment.
I had terrible trouble because this (tubing) used to pop
off. My hand wasn’t strong enough to push it together
and so now that’s it on; I don’t wash this at all. I found
once it comes off, I ﬁnd it hard to get back on.
(Participant 16, nebuliser user for 10 years)
Discarding residual liquid
Any liquid remaining in the nebuliser should be dis-
carded and never kept or reused. In most cases, patients
stated that they nebulised until dryness and no residual
volume remained in the chamber. Many patients
reported not discarding any residual liquid (n=16).
Moreover, as previously described, some interrupted
nebulisation (n=8), resulting in use of medication
present in the nebuliser chamber for up to 24 h, which
may affect drug formulation stability and can be a risk
for contamination. In one case, the patient admitted
reusing residual liquid although she recognised the
importance of discarding it.
Cleaning the nebuliser system
After dismantling the nebuliser and discarding remain-
ing liquid, patients/carers should follow the manufac-
turer’s cleaning instructions. The majority of the
patients did not adhere to good practice with regard to
washing parts in warm soapy water after each use (n=34;
tables 2 and 3), never disinfected nebuliser parts (n=46;
table 3) and few ran the machine empty or with saline
after use.
After cleaning, components should be allowed to dry
naturally and stored in a clean bag. Tubing should be air
Table 3 Method of cleaning, sanitisation/‘sterilisation’ and
drying nebuliser parts
Method of cleaning
Patients
(N=50)
Warm soapy water 16
Tap water 9
Warm water 6
Cold water 2
Hot water 4
Boiling water 4
Tissue 3
Method of sanitisation/‘sterilisation’
Boil 2
Using lime scale tablets 1
Detergent or commercial disinfectant
solution
1
Method of drying
With a cloth or tissue 5
Drain it or leave it to dry naturally 27
Blow it or air dry it with the compressor 3
Never dried it before 15
Table 2 Frequency of cleaning nebuliser parts
Patients (N=50)
Frequency
Facemask/
mouthpiece Chambers Tubing
After each
use
19 20 18
Daily* 10 7 –
Alternate
days
22 –
Twice weekly 4 5 –
Weekly 9 9 –
Monthly 3 4 –
Never 3 3 32
*Daily refers to the patients who reported cleaning their nebuliser
by the end of the day, which, depending on their dosage
frequency, was either after 2, 3 or 4 uses (n=7, 1 and 1).
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retained moisture. However, many patients never dried
the parts after cleaning (n=15; table 3), less than half
stored nebuliser parts in a clean bag after use (n=22)
and few dried the tubing by compressor-air blowing
(n=8).
And that’s dry, but inside there, that is misty, inside,
where the tube goes…You can blow it out with the nebu-
liser; you can blow it out and dry it with the nebuliser.
(Participant 11, nebuliser user for 3 years)
As a result of inadequate cleaning, dirty masks (n=12),
medication chambers with evidence of crystallisation
inside (n=5), blocked tubing (n=3) and stained com-
pressors (n=19) were observed by the researcher.
Maintaining the nebuliser system
Most nebuliser manufacturers recommend that face-
masks/mouthpieces and tubing be replaced every
3 months with daily use, and the British Thoracic
Society advises replacement of such parts at 3–6 monthly
intervals. Disposable nebuliser chambers should be
replaced every 3 months, while durable chambers can
last up to a year if cleaned adequately. Filters should be
checked monthly and replaced if discoloured, and the
compressor should be serviced annually and checked
for electrical faults.
The majority of the patients did not adhere to these
recommendations (table 4), making their own judge-
ments regarding the need for replacements.
Well I can’t see the need to change it when it’s working.
(Participant 35, nebuliser user for 5 years)
I’ve never done the ﬁlters, I must admit. I’ve never both-
ered a great deal with them because there seems to be a
ﬂow you know, a good ﬂow of air, but I realise that it
should be something that I looked at, because I’ve got
no instructions on the thing because it doesn’t belong to
me. (Participant 6, nebuliser user for 6 months)
As a result of inadequate maintenance, patients either
overused some parts, or used damaged components,
which may adversely affect therapy. Damaged or
overused parts included: facemasks with overly stretched
elasticated bands (n=5), compressors with a broken lid
(n=2), cracked nebuliser caps (n=2), damaged/disco-
loured tubing (n=13), damaged/discoloured mask
(n=5), damaged/discoloured chamber (n=9) and disco-
loured ﬁlters (n=11).
Some patients repaired damaged items: repairing the
compressor lid with string (n=1), adhesive tape around a
cracked nebuliser cap or chamber (n=2), cutting off
damaged parts of tubing (n=2) and using pins to secure
elasticated bands of facemasks (n=1). Wrapping tape
around the nebuliser cap/chamber resulted in inad-
equate cleaning, cut tubing resulted in failure to
connect properly to the compressor and using pins can
result in an ill-ﬁtting facemask. Additionally, there was
evidence of poor equipment use: equipment not placed
10 cm from other objects (n=27), the compressor used
on the ﬂoor/couch to minimise noise (n=16), the com-
pressor covered with a blanket during use (n=3) and the
compressor ‘holed’ to reduce operating noise (n=1).
Patients’ reports of information received
Thirty-one patients did not feel that they had been
adequately informed regarding the use of nebuliser
therapy. Twelve recalled receiving information only
about dose frequency and seven remembered being
informed about how to use and clean the nebuliser.
DISCUSSION
All participants in this study encountered problems with
their nebulisers. Teale et al
13 estimated a 50% prevalence
of problems with nebuliser use among elderly patients
with COPD who were prescribed a nebuliser and
recruited through a hospital, and who received compre-
hensive instruction on its use. However, the present
study provides a more representative setting where most
(80%) of the patients acquired their nebuliser through
a route other than the hospital, and most had received
no instruction on its use.
Problems were reported with all aspects of nebuliser
use, many of which could impact on clinical outcomes.
For example, incorrectly assembling components such as
an inverted facemask or a loosely ﬁtted nebuliser cap is
Table 4 Frequency of replacing nebuliser parts and servicing the compressor
Patients (N)*
Frequency Facemask/mouthpiece Chambers Tubing Filter Compressor
Weekly –– – – –
Monthly 2 2 2 2 –
3 monthly 6 5 4 3 –
6 monthly 4 4 3 1 –
Annually 3 3 3 – 9
Discoloured/damaged 10 9 13 11 2
Never 24 26 21 31 39
*One patient replaced all the parts after two or three uses, and one patient was using the nebuliser system without the outlet/inlet filter.
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lungs. In instances where the vaporiser head was
missing, no aerosol would be produced during nebulisa-
tion. Failure to ﬁt the facemask, or use the mouthpiece
correctly, results in aerosol escaping to the surrounding
atmosphere rather than entering the airways. An ill-
ﬁtting mask may also result in drug deposition on the
patient’s face or in the eyes,
19 potentially causing
adverse effects such as glaucoma.
20 21 Preference for
facemasks or mouthpieces varied between participants.
To promote effective therapy, patients should be given
the choice of interface that they ﬁnd most comfortable
and easy to use. Ideally, all patients supplied with a
mouthpiece should keep a facemask in case of an emer-
gency. Problems with manual dexterity, having a poor
grip, difﬁculty opening vials and poor eyesight were con-
tributory factors to problems for many patients.
Confusion about the amount of saline required to
dilute drug formulations or use of other diluents was
identiﬁed. Substituting isotonic saline with water is haz-
ardous, producing hypotonic solutions that may cause
bronchoconstriction.
22 Moreover, there was considerable
confusion regarding whether dilution was necessary.
This study has shown that patients had poor under-
standing of correct inhalation technique. Breathing
technique is considered less critical for nebulisers com-
pared with pMDIs or DPIs. COPD is characterised by
airway constriction, resulting in limited aerosol depos-
ition in the lungs and in particular into the smaller
airways.
23 Body posture can affect the area of drug
deposition and trying out certain body manoeuvres can
help in targeting poorly ventilated airways. There was
uncertainty among patients in regard to achieving
optimal efﬁcacy. The majority of patients in this study
were found to be nose breathing. Heyder et al
24 deter-
mined that a larger amount of aerosol is needed to com-
pensate for loss in the nose. Inhaling slowly and deeply
through the mouth and breath holding for a few
seconds (when possible) before exhalation can increase
the amount of drug deposited in the airways by at least
two-fold compared with normal tidal breathing.
25
Although slow, deep breathing with breath holding may
not always be possible, especially for patients with severe
disease, such inhalation technique is beneﬁcial when-
ever possible.
Patients in this study undertook inadequate cleaning
and maintenance procedures. Previous studies have
found problems with cleaning to be frequent.
13 18
Adherence to manufacturers’ cleaning and maintenance
instructions is essential for correct operation of the
equipment.
26 Most recommend cleaning parts after each
use with warm soapy water, with disinfection/boiling at
least weekly. Some recommend the nebuliser be run
empty, or with saline, after use. Inadequate cleaning and
drying affect nebuliser performance and can lead to sub-
therapeutic outcomes as well as being an infection risk.
Inadequately cleaned and maintained nebulisers have
been identiﬁed as potential reservoirs for serious
pathogens, such as Pseudomonas spp, which may be deliv-
ered to the lung.
27–29 The potential for occurrence of an
exacerbation, and the need for strategies to improve
adherence to nebuliser cleaning and sanitisation regimes
are clear.
With regard to maintaining the nebuliser and com-
pressor, the infrequent replacement of the disposable
parts of the nebuliser system and lack of servicing have
been previously documented.
15 17 18 Blockage of inlet
ﬁlters and lack of servicing affect compressor perform-
ance.
14 In this study, discoloured ﬁlters were observed
and a lack of servicing of the compressor was especially
prominent.
Strengths of this study are that it represents a compre-
hensive examination of the whole process of nebuliser
use by using a structured observation to document prac-
tices combined with patients’ own explanations of their
experiences, concerns and rationale. While the study
included patients from across 38 medical practices and
intermediate care, it is limited in that it was undertaken
in only one part of Greater London and may not reﬂect
provision and support elsewhere.
Nebulisers remain an important part of therapy for
many patients with COPD, including those with severe
disease. However, this study has identiﬁed that partici-
pants experienced difﬁculties with all aspects of nebu-
liser use and devised strategies to overcome these, many
of which would be anticipated to have an impact on clin-
ical outcomes and potentially contribute to treatment
failures. They described a service which did not always
meet their needs in terms of supply and maintenance of
equipment and associated support. Ensuring appropri-
ate systems, services and support for these patients
should be a priority for healthcare providers if optimal
outcomes from medication are to be achieved, reducing
disease burden for patients and promoting cost-effective
care.
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